The p53 isoforms are differentially modified by Mdm2

被引:32
|
作者
Camus, Suzanne [2 ]
Menendez, Sergio [2 ]
Fernandes, Kenneth [1 ]
Kua, Nelly [2 ]
Liu, Geng [3 ]
Xirodimas, Dimitris P. [3 ]
Lane, David P. [2 ]
Bourdon, Jean-Christophe [1 ]
机构
[1] Univ Dundee, Coll Med, Ctr Oncol & Mol Med, Dundee, Scotland
[2] Natl Univ Singapore, Inst Mol & Cell Biol, Singapore 117548, Singapore
[3] Ctr Rech Biochim Macromol, UMR 5237, Montpellier, France
关键词
p53; isoform; Mdm2; degradation; ubiquitination; neddylation; nedd8; splice; nutlin; INFLUENCES SIRNA EFFICACY; P53-RELATED PROTEIN P73; TUMOR-SUPPRESSOR P53; C-TERMINUS; IN-VIVO; TRANSCRIPTIONAL ACTIVITY; FUNCTIONAL-ANALYSIS; STABILITY CONTROL; ONCOPROTEIN MDM2; DNA-DAMAGE;
D O I
10.4161/cc.20119
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The discovery that the single p53 gene encodes several different p53 protein isoforms has initiated a flurry of research into the function and regulation of these novel p53 proteins. Full-length p53 protein level is primarily regulated by the E3-ligase Mdm2, which promotes p53 ubiquitination and degradation. Here, we report that all of the novel p53 isoforms are ubiquitinated and degraded to varying degrees in an Mdm2-dependent and -independent manner, and that high-risk human papillomavirus can degrade some but not all of the novel isoforms, demonstrating that full-length p53 and the p53 isoforms are differentially regulated. In addition, we provide the first evidence that Mdm2 promotes the NEDDylation of p53 beta. Altogether, our data indicates that Mdm2 can distinguish between the p53 isoforms and modify them differently.
引用
收藏
页码:1646 / 1655
页数:10
相关论文
共 50 条
  • [31] MDM2 chaperones the p53 tumor suppressor
    Wawrzynow, Bartosz
    Zylicz, Alicja
    Wallace, Maura
    Hupp, Ted
    Zylicz, Maciej
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (45) : 32603 - 32612
  • [32] Mdm2 facilitates the association of p53 with the proteasome
    Kulikov, Roman
    Letienne, Justine
    Kaur, Manjit
    Grossman, Steven R.
    Arts, Janine
    Blattner, Christine
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (22) : 10038 - 10043
  • [33] Reactivation of p53 via MDM2 inhibition
    Kim, E. S.
    Shohet, J. M.
    CELL DEATH & DISEASE, 2015, 6 : e1936 - e1936
  • [34] P53 AND MDM2 IMMUNOSTAINING IN PULMONARY BLASTOMAS
    PACINDA, SJ
    LANGSTON, C
    GONDO, MM
    BROWN, RW
    FRANKLIN, RB
    CARMONA, PA
    CAGLE, PT
    LABORATORY INVESTIGATION, 1995, 72 (01) : A151 - A151
  • [35] Mdm2 promotes the rapid degradation of p53
    Ygal Haupt
    Ruth Maya
    Anat Kazaz
    Moshe Oren
    Nature, 1997, 387 : 296 - 299
  • [36] On the biosynthesis of an inhibitor of the p53/MDM2 interaction
    Duncan, SJ
    Williams, DH
    Ainsworth, M
    Martin, S
    Ford, R
    Wrigley, SK
    TETRAHEDRON LETTERS, 2002, 43 (06) : 1075 - 1078
  • [37] RYBP stabilizes p53 by modulating MDM2
    Chen, Deng
    Zhang, Jianbing
    Li, Mao
    Rayburn, Elizabeth R.
    Wang, Hui
    Zhang, Ruiwen
    EMBO REPORTS, 2009, 10 (02) : 166 - 172
  • [38] Mdm2: Keeping p53 under control
    Piette, J
    Neel, H
    Marechal, V
    ONCOGENE, 1997, 15 (09) : 1001 - 1010
  • [39] Heterogeneous Hydration of p53/MDM2 Complex
    Guo, Zuojun
    Li, Bo
    Dzubiella, Joachim
    Cheng, Li-Tien
    McCammon, J. Andrew
    Che, Jianwei
    JOURNAL OF CHEMICAL THEORY AND COMPUTATION, 2014, 10 (03) : 1302 - 1313
  • [40] MDM2 and p53 expression in ampullary adenocarcinomas
    Perysinakis, I.
    Leontara, V.
    Minaidou, E.
    Karambogias, C.
    Choreftaki, T.
    Zografos, G.
    Kouraklis, G.
    VIRCHOWS ARCHIV, 2015, 467 : S126 - S126